Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Figures corrected NBB
Corrected annual account filed for 2023.
Financials
Financial year 2025
European Medical Solutions from Elsene, company number BE0460798795, closed financial year 2025 with a result of € 338,479 after tax. For that financial year European Medical Solutions recorded revenue of € 606,595 and equity of € 45.9 million. Compared with financial year 2024, the result moved from € 168,430 to € 338,479. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 10, 2026.
€ 45.9 million
▲ 1% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 338,479
▲ 101% vs 2024
Profit after tax over the fiscal year.
€ 376,813
▲ € 329,465 vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € -58.8 million.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 587,152
▼ 7% vs 2024
Supplier invoices still open on the last day of the fiscal year. Pays suppliers within 295 days on average.
€ 6,655
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|
| Revenue | - | - | € 606,595 | |
| Profit after taxes | € -20,344 | € 168,430 | € 338,479 | ▲ 101% |
| Equity | € 45,430,544 | € 45,598,974 | € 45,937,453 | ▲ 1% |
| Total debts | € 1,269,792 | € 946,882 | € 802,203 | ▼ 15% |
| Cash | € 420,208 | € 47,348 | € 376,813 | ▲ € 329,465 |
| Retained profit | € -59,271,173 | € -59,102,743 | € -58,764,264 | ▲ € 338,479 |
| Bank debt | € 41,517 | € 0 | € 0 | |
| Balance sheet total | € 47,091,219 | € 46,545,856 | € 46,739,656 |
Key figures of European Medical Solutions, fiscal years 2023 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to European Medical Solutions?
What happened at European Medical Solutions in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- Julien Delpech stepped down as director. NBB
- Samuel SANCERNI stepped down as director. NBB
- New annual accounts for financial year 2025: profit of € 338,479 (▲ 101% vs 2024). Source: NBB ↗
- Marie-Laurence BORIE stepped down as director. NBB
- Jean-François GENDRON stepped down as director. NBB
- Régis ROCHE stepped down as director. NBB
- Julien Delpech became a director. NBB
- Samuel SANCERNI became a director. NBB
In short
From € 20,344 loss in 2023 to € 338,479 profit in 2025.
Paid € 179,460 in corporate taxes since 2023.
Best year ever: 2025, with € 338,479 profit.
A new publication or filing at European Medical Solutions? We notify you, reason included.
Follow European Medical SolutionsDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
It owns 100% of APELEM and 100% of AXS MEDICAL itself.
Directors
According to the 2025 annual accounts
Julien Delpech
Director
since 2025 · until 2029
Marie-Laurence BORIE
Director
since 2023 · until 2026
Régis ROCHE
Director
since 2022 · until 2025
Jean-François GENDRON
Chairman of the board
since 2022 · until 2026
Samuel SANCERNI
Managing director
since 2025 · until 2029
Establishments
Establishment units
Physical locations of this company
Louizalaan 231
1050 Elsene
Arianelaan 5
1200 Sint-Lambrechts-Woluwe
Active since 19 June 1997
Rue des Chasseurs-Ardennais 7
4031 Liège
Active since 28 June 2016
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Website
Technologies
Hosting & Email
Email provider
Self-hosted
Hosting
WAN2MANY-AS, FR
Domain
Domain
dms-imaging.com
Registered
2016-09-29
Registrar
Infomaniak Network SA
Expires
2026-09-29
Website info
Features
Security
Details
- Company number
- 0460.798.795
- VAT number
- BE 0460.798.795
- Registered office
- Louizalaan 231, 1050 Elsene
- Names & denominations
- European Medical Solutions · EMS
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 5 June 1997
- Peppol
- Active · Active since 15 Jan 2026
- Contact
- dms-imaging.com [email protected]
- Activities · NACE
Vervaardiging van andere chemische producten, neg
Vervaardiging van overige chemische producten
Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied
Activiteiten van medische beeldvorming en medische laboratoria
Speur- en ontwikkelingswerk op natuurwetenschappelijk gebied
Medische laboratoria
Activiteiten van medische laboratoria
Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied